Clinical effects of calcium channel blockers and renin-angiotensin- aldosterone system inhibitors on changes in the estimated glomerular filtration rate in patients with polycystic kidney disease

Clinical and Experimental Nephrology

Volumn 14, Issue 6, 2010, Pages 573-577

  Mitobe, Michihiro ^a   Yoshida, Takumi ^a   Sugiura, Hidekazu ^a   Shiohira, Shunji ^a   Shimada, Katsunori ^b   Nitta, Kosaku ^a   Tsuchiya, Ken ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b STATZ Institute Inc   (Japan)

Author keywords

Calcium channel blocker; eGFR; Hypertension; Polycystic kidney disease; Renin angiotensin aldosterone system inhibitor

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BENIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CILAZAPRIL; CILNIDIPINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN; NIFEDIPINE; OLMESARTAN; TELMISARTAN; VALSARTAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY POLYCYSTIC DISEASE; MALE; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; RENIN-ANGIOTENSIN SYSTEM; RETROSPECTIVE STUDIES;

EID: 78650953274     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-010-0329-5     Document Type: Article

References (19)

1. D Wang S Strandgaard 1997 The pathogenesis of hypertension in autosomal dominant polycystic kidney disease J Hypertens 15 925 933 1:STN:280: DyaK2svmt12mtw%3D%3D 10.1097/00004872-199715090-00002 9321739 (Pubitemid 27399806)
2. BK Yoder S Mulroy H Eustace C Boucher R Sandford 2006 Molecular pathogenesis of autosomal dominant polycystic kidney disease Expert Rev Mol Med 8 1 22 10.1017/S1462399406010362 16515728 (Pubitemid 43125675)
3. K Hanaoka F Qian A Boletta AK Bhunia K Piontek L Tsiokas, et al. 2000 Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents Nature 408 990 994 1:CAS:528:DC%2BD3MXhslWqtw%3D%3D 10.1038/35050128 11140688 (Pubitemid 32101647)
4. DH Vandorpe MN Chernova L Jiang LK Sellin S Wilhelm AK Stuart-Tilley, et al. 2001 The cytoplasmic C-terminal fragment of polycystin-1 regulates a Ca2+-permeable cation channel J Biol Chem 276 4093 4101 1:CAS:528: DC%2BD3MXht1Ggu7g%3D 10.1074/jbc.M006252200 11044446
5. SM Nauli FJ Alenghat Y Luo E Williams P Vassilev X Li, et al. 2003 Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells Nat Genet 33 129 137 1:CAS:528:DC%2BD3sXnsFSksw%3D%3D 10.1038/ng1076 12514735 (Pubitemid 36177063)
6. BK Yoder X Hou LM Guay-Woodford 2002 The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia J Am Soc Nephrol 13 2508 2516 1:CAS:528:DC%2BD38XntVyntr0%3D 10.1097/01.ASN.0000029587.47950.25 12239239
7. SM Nauli S Rossetti RJ Kolb FJ Alenghat MB Consugar PC Harris, et al. 2006 Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction J Am Soc Nephrol 17 1015 1025 1:CAS:528:DC%2BD28XjvFSqsbk%3D 10.1681/ASN.2005080830 16565258
8. T Yamaguchi SJ Hempson GA Reif AM Hedge DP Wallace 2006 Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells J Am Soc Nephrol 17 178 187 1:CAS:528:DC%2BD28XhtFyqu7s%3D 10.1681/ASN.2005060645 16319189
9. S Nagao K Nishii D Yoshihara H Kurahashi K Nagaoka T Yamashita, et al. 2008 Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy/+ rat Kidney Int 73 269 277 1:CAS:528: DC%2BD1cXmsVyktQ%3D%3D 10.1038/sj.ki.5002629 17943077
10. Y Kanno H Okada K Moriwaki S Nagao H Takahashi H Suzuki 2002 The effects of antihypertensive agents on the survival rate of polycystic kidney disease in Han:SPRD rats Hypertens Res 25 939 943 1:CAS:528:DC%2BD3sXhtVGjsLg%3D 10.1291/hypres.25.939 12484519
11. Y Higashikuni N Ishizaka Y Ishizaka E Toda R Nagai M Yamakado 2008 Relationship between blood pressure and chronic kidney disease in the Japanese population: the lower the better even in individuals without hypertension? Hypertens Res 31 213 219 1:CAS:528:DC%2BD1cXmt1artrw%3D 10.1291/hypres.31.213 18360039 (Pubitemid 351461099)
12. K Nutahara E Higashihara S Horie K Kamura K Tsuchiya T Mochizuki, et al. 2005 Calcium channel blocker versus angiotensin II receptor blocker in autosomal dominant polycystic kidney disease Nephron Clin Pract 99 c18 c23 1:CAS:528:DC%2BD2MXhs1Wksw%3D%3D 10.1159/000081790 15637459
13. T Ecder AB Chapman GM Brosnahan CL Edelstein AM Johnson RW Schrier 2000 Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease Am J Kidney Dis 35 427 432 1:CAS:528:DC%2BD3cXhvFGiu7o%3D 10.1016/S0272-6386(00)70195-8 10692268
14. E Imai M Horio K Nitta K Yamagata K Iseki Y Tsukamoto, et al. 2007 Modification of the modification of diet in renal disease (MDRD) study equation for Japan Am J Kidney Dis 50 927 937 10.1053/j.ajkd.2007.09.004 18037093 (Pubitemid 350130278)
15. H Matsunaga BA Stanton FA Gesek PA Friedman 1994 Epithelial Ca2+ channels sensitive to dihydropyridines and activated by hyperpolarizing voltages Am J Physiol 267 C157 C165 1:CAS:528:DyaK2cXlsV2ms7s%3D 7519395
16. MI Zhang RG O'Neil 1996 Regulated calcium channel in apical membranes renal proximal tubule cells Am J Physiol 271 C1757 C1764 1:CAS:528: DyaK28XntFylurg%3D 8944661
17. P Koulen Y Cai L Geng Y Maeda S Nishimura R Witzgall, et al. 2002 Polycystin-2 is an intracellular calcium release channel Nat Cell Biol 4 191 197 1:CAS:528:DC%2BD38XitF2hur4%3D 10.1038/ncb754 11854751 (Pubitemid 34218192)
18. T Yamaguchi DP Wallace BS Magenheimer SJ Hempson JJ Grantham JP Calvet 2004 Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype J Biol Chem 279 40419 40430 1:CAS:528:DC%2BD2cXnslWnsLw%3D 10.1074/jbc.M405079200 15263001 (Pubitemid 39287631)
19. T Fujita K Ando H Nishimura T Ideura G Yasuda M Isshiki, et al. 2007 Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease Kidney Int 72 1543 1549 1:CAS:528:DC%2BD2sXhtlKltLrJ 10.1038/sj.ki.5002623 17943080 (Pubitemid 350199443)